Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Free Thinking: Behavioural economics

    March 27, 2015 |  

    Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

    Books espousing behavioural economic theories, such as “Thinking Fast and Slow” authored by Daniel Kahneman, have become essential reading for market researchers looking to improve their understanding of how people think, feel and behave.

    This theory can be very useful in consumer research, where we already know the power brands have on influencing purchase decisions. But can behavioural economics theory be applied to the pharmaceutical healthcare industry, where treatment decisions are often made in a highly regulated environment and by educated professionals using sound, rational judgement?

    Download and read the complimentary whitepaper at http://bit.ly/1L5YhyM

    We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. 

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Event: Intellus Worldwide Summit 2019

    Visit us on stand number 311

    Blog: The Future of Food Allergy? The Emergence of Targeted Allergy Treatments

    Research Analyst Rachel Arthurs explores how public exposure to the complications of food allergy has affected attitudes toward treatment.In recent years, there has been a noticeable shift in the increased...

    News: Research Partnership is listed in the Alantra Pharma Fast 50 annual report

    The best performing privately-owned UK pharmaceutical businesses were revealed earlier this month with the publication of Pharma Times’ Alantra Pharma Fast 50 annual report.Read more about this report here

    Event: Blending data science and market research at the Data Analytics & Insight conference

    Last month Analytics Director Misti Paul attended the Data Analytics & Insight Conference. In our latest blog post she reflects on the presentations that were given and what lessons can be...

    Presentation: Optimize your digital assets with UX research

    US Director Liza Pliss recently presented the paper 'Optimize your digital assets with UX research' at the PMR Conference in New Jersey, USA. Don't worry if you missed it though,...

    Report: Living With Rheumatoid Arthritis 2019 reports now available to purchase

    We have published new Living with Rheumatoid Arthritis reports in 5EU, Japan and Canada. The reports consist of 30-minute quantitative online and qualitative telephone interviews with RA patients. Read more on...

    Infographic: Rheumatoid arthritis (RA)

    An overview of the RA biologic patientOur RA market snapshot offers an introduction to the real world patient data collected by our Therapy Watch RA study. The snapshot looks at...

    Webcast: Navigating new frontiers: Ways to find space in the future RA market

    In partnership with pharmaphorumView the webcast »The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors, are shaking up a once-stable market.Although there are only...

    Live Webinar: China in the fast lane: How to play and win in the world’s hottest emerging market

    Tuesday 16th April 2019 10:00 EST/ 15:00 GMT / 16:00 CEST

    Pegasus expands Pharma team with senior hires

    Five new recruits support further growth of the Pharma & Life Sciences team